AdVec, Inc.
Ancaster, CA· latest recorded location
AdVec, Inc. is named on 8 US grants and 5 published applications in this corpus. Its most frequent classification is C12N (Microorganisms or enzymes).
- Granted patents
- 8
- Published applications
- 5
- Inventors
- 12
- Granted in 2026 so far
- 0
- Most recent grant
- 13 Mar 2007
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 3 |
| 2004 | 0 | 1 |
| 2005 | 1 | 0 |
| 2006 | 3 | 1 |
| 2007 | 1 | 0 |
By publication year.
Technology areas
Share of 13 documents
Recent patents
- Production of adenovirus vectors with reduced levels of replication competent adenovirus contamination13 Mar 2007US 7,189,561 B2
- System for production of helper dependent adenovirus vectors based on use of endonucleases14 Nov 2006US 7,135,187 B2
- Recombinase-based system for combustion of adenovirus vectors7 Nov 2006US 7,132,290 B2
- Helper dependent adenovirus vectors based on integrase family site-specific recombinases16 May 2006US 7,045,347 B2
- Adenoviruses for control of gene expression13 Dec 2005US 6,974,694 B2
- Production of adenovirus vectors with reduced levels of replication competent adenovirus contamination23 Mar 2006US 2006/0063259 A1
- Recombinase-based system for construction of adenovirus vectors22 Jul 2004US 2004/0142470 A1
- System for production of helper dependent adenovirus vectors based on use of endonucleases11 Dec 2003US 2003/0228280 A1
- Helper dependent adenovirus vectors based on integrase family site-specific recombinases26 Jun 2003US 2003/0118554 A1
- Adenoviruses for control of gene expression29 May 2003US 2003/0100523 A1
Most cited
By later US patents
- Adenoviral vector system comprising Cre-loxP recombination82US 5,919,676 A1999
- Adenovirus vectors for gene therapy46US 6,140,087 A2000
- Adenoviruses for control of gene expression39US 6,120,764 A2000
- Helper dependent adenovirus vectors based on integrase family site-specific recombinases11US 7,045,347 B22006
- Production of adenovirus vectors with reduced levels of replication competent adenovirus contamination1US 7,189,561 B22007